Company Filing History:
Years Active: 1996-1998
Title: Christine Breugnot: Innovator in Medicinal Chemistry
Introduction
Christine Breugnot is a prominent inventor based in Paris, France. She has made significant contributions to the field of medicinal chemistry, holding three patents that showcase her innovative spirit and dedication to therapeutic advancements.
Latest Patents
Her latest patents include the development of substituted 2,2-dimethyl-omega-phenoxyalkanoic acids and esters. These compounds are defined by a specific formula and include their corresponding enantiomers, diastereoisomers, and physiologically tolerable salts. The products of this invention have potential therapeutic applications. Another notable patent involves substituted phenoxyisobutyric acids and esters, which can also be utilized as medicaments. These compounds are similarly defined by a specific formula and their physiologically tolerable salts can be used therapeutically.
Career Highlights
Christine Breugnot is associated with Adir Et Compagnie, where she continues to push the boundaries of medicinal chemistry. Her work has been instrumental in developing new therapeutic compounds that can improve patient outcomes.
Collaborations
She collaborates with esteemed colleagues such as Gilbert Regnier and Claude Guillonneau, contributing to a dynamic research environment that fosters innovation.
Conclusion
Christine Breugnot's contributions to medicinal chemistry through her patents reflect her commitment to advancing therapeutic solutions. Her work continues to inspire and pave the way for future innovations in the field.
Inventor’s Patent Attorneys refers to legal professionals with specialized expertise in representing inventors throughout the patent process. These attorneys assist inventors in navigating the complexities of patent law, including filing patent applications, conducting patent searches, and protecting intellectual property rights. They play a crucial role in helping inventors secure patents for their innovative creations.